Implementing CGP and HRD Testing In-House for Advanced Cancer Care

Explore the implementation of Comprehensive Genomic Profiling (CGP) and Homologous Recombination Repair Deficiency (HRD) testing in a large US healthcare system through this informative 38-minute webinar. Join presenters Carlo Bifulco, MD, and Brian Piening, PhD, as they delve into the impact of introducing an HRD assay at their institution. Learn about the association between HRD and response to poly-ADP-ribose polymerase inhibition (PARPi) therapy in advanced ovarian cancer. Discover how combining CGP and HRD analyses enables clinicians to maximize clinical information, matching patients with approved therapies or relevant clinical trials. Gain insights into the implementation process, technical considerations for HRD testing, concordance with other HRD assays, and the benefits of offering in-house CGP and HRD testing. This presentation provides valuable knowledge for healthcare professionals interested in advancing precision medicine and improving patient care in oncology.

Implementing CGP + HRD testing in house in a large US Healthcare System